admin – Page 27 – Swanson Reed | Specialist R&D Tax Advisors

Resolve Medical Bills Secures $3.3M in Seed Funding

Resolve Medical Bills, a New Hampshire startup tackling the nation’s medical debt, has successfully raised $3.3. Million in seed funding following a round led by AlleyCorp. Additional support was found with the founders of category defining companies such as Funding Circle, Collective Health, Collective Medical, Nomi, Compass, Seamless, and more.

The company was founded in response to the nation’s growing medical debt. In fact, recent studies have shown that 50% of Americans are currently in medical debt. Further studies have shown that a large portion of issued medical bills contain errors and are grossly overcharged. Resolve’s founder, Braden Pan, suffered a serious accident and was met with bill after bill in the months that followed. He partnered with Endurance Companies to form the company in 2019 and has since grown it to become one of the leading medical billing advocates in the US.

Resolve has built a platform to review, negotiate, and lower medical bills on behalf of patients. The platform utilizes proprietary data algorithms to scan and detect pricing issues, coding and/or billing errors. Trained negotiators then take over to secure fair rates and appeal insurance denials. To date, the company has relieved nearly $20M in medical debt, averaging 60-65% savings.

The new funding will help support the company’s growth. They currently employ 22 full-time staff and intend to expand soon with the addition of a Chief of Staff, Head of Product, and a number of software developers. The funding will also support the development and growth of their platform and algorithms, further automating the process and increasing capacity and accuracy.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Polaris Genomics Receives $100K and Will Continue Research on their PTSD Genomic Test

Polaris Genomics, a biotech startup, has announced their research will continue thanks to a $100,000 grant from the Maryland Industrial Partnership Program (MIPS). This grant matches a first grant awarded by MIPS back in the fall of 2020.

The first grant allowed Polaris to begin partnering with researchers at the University of Maryland Baltimore, and with this second grant in place, that research can proceed.

The company brought the first and only PTSD genomic test to the industry, calling it PTS-ID. This genomic blood test is thought to identify persons with PTSD, measure the disease severity, and detect treatment response. The research will continue to evaluate PTS-ID’s efficacy and performance.

Early research had been conducted with a test pool comprising mostly white males. Their tests were then expanded, creating a small cohort of 69 African American men and women, allowing the researchers to observe how their biomarkers performed in a wider population. With a growing statistical significance in the data, the company intends to initiate Phase Two.

“Phase two will allow us to validate these findings with a larger group and to test the biomarkers’ ability to detect changes with treatment,” said Dr. Daniel J Roche, PhD, Assistant Professor Psychiatry at the University of Maryland School of Medicine and the Maryland Psychiatric Research Center.

The second grant is crucial to the mission of better serving veterans, first responders, frontline workers, and trauma-impacted communities alike. Based on the genomic insights and research outcomes, Polaris is moving rapidly towards product commercialization.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

PrologMobile has Secured $1M in Funding for their Device Intelligence Platform

PrologMobile, a tech company set on revolutionizing the way customers and businesses access device data, has successfully raised $1 million in funding from Atlanta-based Valor Ventures.

The company, who’s known as the reverse supply chain startup, intends to use this funding to deepen their roots in Atlanta’s tech ecosystem. This funding will help in this endeavor, expanding their staff and solidifying their presence in Atlanta.

The company has spent years developing a Device Intelligence Platform meant to provide value-based decisioning analytics. They’ve already begun providing these analytics for about 20% of the global reverse supply chain for mobile devices.

This mission came about when the company determined that no one in the global reverse supply chain for mobile devices had a good idea of what they are buying or selling. Mobile devices are complex with many interacting parts that need to be considered. PrologMobile’s platform sets out to provide a better way for devices to be analyzed, prices, and presented for resale.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Soiltech Wireless Secures $2.5M in Seed Funding for their Remote Monitoring AgTech

Idaho-based Soiltech Wireless Inc., a startup focused on remote crop monitoring and traceability from field to transport and storage, has announced the close of a seed funding round bringing in $2.5 million.

The funding will go towards accelerating growth, as the company strives to bring their product to customers. Beyond this, the funding will also help drive the development of the Soiltech software platform which will aid in the collaboration across the agriculture supply chain. This collaboration will deliver enhanced insights to farmers, advisors, processors, and input companies alike.

After a long stint of R&D, the product is set to improve crop quality, increase yields, reduce costs, and lower environmental impact. The technology includes proprietary sensors which would arrive pre-configured, pre-charged, and ready to deploy.

The company began development with the intention of overcoming gaps and challenges in a crop’s production cycle. Their wireless monitoring makes real-time insights possible. They have taken a grassroots approach to innovation, working with growers, agriculture scientists, and industry researchers to make sure its technology solution was addressing real pain points, as well as being simple-to-use, affordable and of high-value for all farmers.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Blustream Corp Secures $5.2M in Series A Funding

Massachusetts-based Blustream Corp. has announced the successful close of their Series A funding round which brought in $5.2 million. The company is developing the technology needed to connect companies to customers through product engagement.

The funding round was led by PBJ Capital of Lincoln and Gutbrain Ventures of Boston with participation from existing investors, including The Zenie Group of Maine and York IE of New Hampshire, the company announced on Tuesday.

Blustream began when its founder, Bob Bean, had a product problem and no solution. With a crack in his beloved guitar and no way to fix it, he tried to reach out to Bob Taylor, the President of Taylor Guitars to try and find a solution. In the same breadth, he realized how much this connectivity is needed across any market. Thus was born the mission to connect companies and customers via product engagement, reducing the need to worry about broken, cracked, and failing products.

What came next was years of building the startup, raising $3 million in funding in 2020 and now the recent Series A round. The latest funding is earmarked for product development and expansion into new industries. This includes investments in their R&D department as well as the expansion of their sales and marketing staff.

Customer-engagement is built with personalized product messages and tracking after-sale product engagement data. With product engagement data, companies can create a direct channel with their customers to drive revenue, retention, and referrals.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

SAFI-Tech and Indium Corp. Partner Up for SAFI-Tech’s Supercooled Soldering Technology

Iowa-based SAFI-Tech has announced a partnership with Indium Corporation. SAFI-Tech has set their sights on developing a no-heat and low-heat solder and metallic joining products. This partnership will bring this technology to customers, allowing them to explore the unique opportunities available with supercooled solder materials.

Their technology is a supercooled liquid metal particle which can allow manufacturers to solder on flexible substrates without the need for heat. The liquid particles are about one-fiftieth the size of a human hair and are filled with liquid metal. When popped, the particles release the encapsulated liquid metal which quickly solidifies, creating a solder joint. This unique process allows soldering to take place at room temperature. Removing heat from electronics manufacturing enables smaller, thinner, and flexible designs, currently unachievable with standard materials and processes.

This partnership has come just two years after SAFI-Tech was awarded an SBIR grant of $200,000 from the Department of Energy for research into their supercooled liquid metal technology.

“We’re always looking for innovative materials solutions that can give our customers ways to overcome current limitations of solder products,” said Indium Corporation President and COO Ross Berntson. “SAFI-Tech’s supercooling platform is a unique approach that has the potential to be a solution across a variety of applications.”

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Sortera Alloys Partners with Novelis to Improve Automotive Alloy Recycling

Sortera Alloys, Inc.,creators of proprietary artificial intelligence (AI) focused on sorting automotive metals, has announced a strategic partnership with Novelis. Inc. Novelis is the leading sustainable aluminum solutions provider.

The partnership will bring Sortera’s patented technologies to Novelis’ production process, allowing the company to recycle and reuse higher amounts of both automotive post-production and post-consumer scrap.

In this day and age, mixed aluminum alloys cannot be re-separated into their individual base alloys. This means high-value alloys are forced into lower value uses. The goal is to use Sortera’s technology, which uses their AI along with novel data analytics and sensors, to tackle this limitation, bringing another high-value life to the alloys.

This partnership will ensure Novelis can separate the mixed scrap into their individual alloys, recycling them back into the same product and closing the loop. This will allow Novelis to meet original equipment makers’ exacting needs for performance, durability, safety, and design. Novelis has been working towards sustainability goals including a reduction of their carbon footprint by 30% by 2026 and this partnership is a big step in the right direction.

“We are thrilled to work with Novelis, the global leader in sustainable aluminum solutions,” said Michael Siemer, CEO, Sortera Alloys. “Together with existing investors like Chrysalix and Breakthrough Energy Ventures, and now Novelis, we are poised to disrupt the global aluminum recycling space while cutting global emissions and driving a more sustainable industry.”

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

NAPIGEN has Announced $7.85M in Seed Funding for Gene Editing Technology

Delaware-based NAPIGEN, an ag-tech and genetics startup, has successfully raised $7.85 million in an initial seed funding round. The company, which operates out of the Delaware Innovation Space at the DuPont Experimental Station in Alapocas, has had a series of successes recently, including an NIH SBIR grant back in June.

The seed funding comes from a private stock sale led by The Grantham Foundation and RA Capital Management. The company intends to use the funding to apply its mitochondrial gene editing tech for hybrid seed production in wheat and rice. The technology can also be used to develop mitochondrial expression systems for use in plant mitochondria.

NAPIGEN’s technology has unique gene editing capabilities specializing in altering cytoplasmic genomes including mitochondrial and chloroplast DNA. NAPIGEN previously demonstrated use of CRISPR technology for genome editing of organellar DNA in yeast and algae.

The company was founded with the intention of addressing the global food shortage. With a growing population and increasing demand for food, products like grains are essential to feed the world.

“This can only be possible with breaking the biological yield limit of crop plants, which is exactly what we are aiming to do. Yield increases benefit both agriculture and environmental protection by reducing the need for deforestation to create new farmland, as well as decreasing the use of agricultural chemicals” said Dr. Hajime Sakai, co-founder and CEO at NAPIGEN.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Day Three Labs to Study Cannabis as a Treatment for Parkinson’s Disease

Day Three Labs (DTL), is a Colorado-based cannabinoid CPG ingredient manufacturer. With their expertise in the development of these novel cannabis products, the company has set out to evaluate cannabis as a treatment for Parkinson’s Disease.

This mission has come to light after the company announced the world’s first government-sponsored cannabis technology incubator will aid in funding this research.

While the headquarters are in Denver, the research facility is in Israel, where regulations make studying cannabis much easier than in the United States. They are the only company to have passed the first phase of the CanNegev program, a cannabis technology incubator that receives funding from the Israeli government.

With this first phase complete, the company will receive funding and move into phase two. This means initiating the research and data collection for presentation to the Israel Innovation Authority as soon as September.

Through the research program, Day Three Labs plans to study cannabis compounds delivered via its proprietary Unlokt technology as a treatment for Parkinson’s disease symptoms. The funding from CanNegev will enable the company to find the combination of cannabinoids that work best to treat Parkinson’s disease and allow the company to carry the research from the lab to product development.

Parkinson’s Disease affects more than 10 million worldwide. Cannabis has been an approved treatment option in Germany since 2017. However, with the ever growing list of marijuana and cannabis strains and product types, choosing a formulation that is most effective at providing consistent relief is a true challenge. DTL’s research will take advantage of the Unlokt technology which packs cannabis into a natural protein which bypasses the liver, shuttling cannabis directly into the body’s circulation. This allows the cannabinoids and terpenes to be released and absorbed into the bloodstream and should have a beneficial effect.

“Unlokt is a significant leap in technology that will disrupt traditional research and delivery of cannabinoid compounds and beyond,” said Josh Rubin, co-founder and CEO of Day Three Labs. “Utilizing a groundbreaking technology like Unlokt in the adult-use market is revolutionary and game-changing, and creates incredibly enjoyable products, but it only scratches the surface of what this technology is capable of. Our work with CanNegev is just the beginning of the technological advances we are bringing to this fast-growing industry with the hope of eradicating previously untreatable illnesses and conditions and bringing solutions to the cannabis industry that are safer, more efficacious and efficient.”

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

SCiFi Foods’ CRISPR Cultivated Beef Meets Price Parity

forefront of bioscience automated farming equipment

SCiFi Foods is set on creating the next lightbulb. It’s the seemingly simple innovations that really revolutionize our future. The thing about these simple innovations is … they are only simple after they’ve been invented. With that in mind, SCiFi Foods is tackling the daunting task of cruelty-free, sustainable, cultivated meat.

The company’s goals include replicating the same taste, texture, and nutrition as conventional meat without the cost to the planet or the unsustainable practices of raising and farming beef. With their recent breakthrough, their cell-based beef is now 1000 times cheaper to produce.

The California-based startup has recently announced they have achieved price parity with beef using their proprietary cultivated meat food-tech. This comes as the company’s first R&D announcement, and is also a first for the world. SCiFi Foods is officially the first to produce edible cultivated beef cell lines grown in a single-cell suspension.

“We’ve known from day one that by opting to work on cultivated beef, we were choosing a much bigger challenge in terms of the science and technology required,” SCiFi Foods CEO and co-founder Joshua March said in a statement. “However, beef is the ultimate prize—with both the biggest market demand and the biggest climate impact. This breakthrough illustrates the power of our bioengineering strategy, and is a huge testament to our team and the platform they’ve built.”

Their proprietary beef cultivating process uses CRISPR technology. CRISPR began as a controversial technology adapted from a genome editing system that bacteria use for immunity. By capturing and inserting small pieces of DNA from the attacking virus into their own DNA, bacteria create what’s called CRISPR arrays. But for all of its potential, the tech has also brought controversy as studies have found that altering the DNA of embryos or eggs and sperm could cause mutations that create other health threats.

SCiFi Foods has done extensive testing and determined the use of CRISPR is unlikely to pose risks to humans who consume CRISPR-edited cultivated beef. The technology also allows for price parity, with a good chance that cultivated beef prices will drop even further.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.